22 July 2020 | News
Establishment of a new $13 million ARC Industrial Transformation Training Centre
Image credit- shutterstock.com
Monash Institute of Pharmaceutical Sciences (MIPS) in Australia is leading a collaboration of academic and industry partners that has been awarded a $4.7 million grant from the Australian Research Council (ARC) towards establishment of a new $13 million ARC Industrial Transformation Training Centre (ITTC).
MIPS will be the headquarters of the new ARC Training Centre for cryo-electron microscopy of membrane proteins for drug discovery, established in collaboration with the University of Melbourne, University of Wollongong, the Walter and Eliza Hall Institute of Medical Research (WEHI) and industry partners including Catalyst Therapeutics, AstraZeneca, Pfizer, Dimerix Bioscience and Thermo Fisher Scientific.
The ITCC is one of five new ARC Training Centres announced by the Federal Government, and will be dedicated to enabling the power of cryo-electron microscopy to reveal membrane protein structures as a basis for structure-enhanced drug design.
The ITTC will provide new links between academic and commercial partners, providing increased opportunity for generation of new IP and expansion of economic investment into the Australian biotechnology sector.